Nephros (NEPH) Long-Term Investments (2016 - 2018)

Nephros (NEPH) posted quarterly Long-Term Investments of $26000.0 for Q3 2018, down 13.33% quarter-over-quarter from $30000.0 in Q2 2018.

Nephros (NEPH) Long-Term Investments (2016 - 2018) Analysis & Trends

Nephros' Long-Term Investments history runs 3 years deep, the most recent figure standing at $26000.0 for Q3 2018.

In Q3 2018, Long-Term Investments changed N/A year-over-year to $26000.0; the TTM figure through Sep 2018 stood at $26000.0 (changed N/A YoY), while the FY2017 annual figure was $39000.0, down 36.07% from the prior year.
Long-Term Investments for Q3 2018 stood at $26000.0, down from $30000.0 in the prior quarter.
The five-year high for Long-Term Investments was $61000.0 in Q4 2016, with the low at $26000.0 in Q3 2018.
The 3-year median for Long-Term Investments is $34000.0 (2018), against an average of $38000.0.
Peak annual rise in Long-Term Investments reached 36.07% in 2017, while the deepest fall reached 36.07% in 2017.
Nephros' Long-Term Investments stood at $61000.0 in 2016, then sank by 36.07% to $39000.0 in 2017, then plunged by 33.33% to $26000.0 in 2018.
Business Quant data shows NEPH's Long-Term Investments at $26000.0 in Q3 2018, $30000.0 in Q2 2018, and $34000.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	3.41 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	-
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	-
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	-
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	-
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	207.70 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	-
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	-
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	-
10	Nephros	45.71 Mn	41.01 Mn	4.03 Mn	-

Download Data